Use of recombinant human activated protein C in patients with severe sepsis: a French retrospective multicentre study

By Muller Laurent   Jaber Samir   Raillard Alice   Lefrant Jean  

Intensive Care Medicine, Vol. 34, Iss. 5, 2008-05 ,pp. : 977-979

Springer Publishing Company

Access to resources Recommend Favorite

Recombinant human activated protein C in sepsis: previous concerns and current usage

By Haley Michael   Cui Xizhong   Minneci Peter C   Deans Katherine J   Natanson Charles   Eichacker Peter Q  

Therapy, Vol. 1, Iss. 1, 2004-09 ,pp. : 123-129

Future Medicine

Access to resources Recommend Favorite

Recombinant activated factor VII in paediatric cardiac surgery

By Egan Jonathan   Lammi Ahti   Schell David   Gillis Jonathan   Nunn Graham  

Intensive Care Medicine, Vol. 30, Iss. 4, 2004-04 ,pp. : 682-685

Springer Publishing Company

Access to resources Recommend Favorite

The Emerging Role of Recombinant-Activated Factor VII in Neurocritical Care

By Fewel Matthew E.   Park Paul  

Neurocritical Care, Vol. 1, Iss. 1, 2004-01 ,pp. : 19-30

Humana Press, Inc

Access to resources Recommend Favorite

Use of Activated Recombinant Factor VII in Severe Bleeding – Evidence for Efficacy and Safety in Trauma, Postpartum Hemorrhage, Cardiac Surgery, and Gastrointestinal Bleeding

By  

Transfusion Medicine and Hemotherapy, Vol. 39, Iss. 2, 2012-03 ,pp. : 139-150

Karger

Access to resources Recommend Favorite